Windlas Biotech Ltd.
Snapshot View

View in App

Prices View details >>

249.00 +7.60 ▲3.2%

07 February 2023, 04:01:00 PM
Volume: 512

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.windlasbiotech.com
Market Cap 517.71 Cr.
Enterprise Value(EV) 432.50 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 21.09 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 11.81 Trailing Twelve Months Ending 2022-09
Industry PE 32.80 Trailing Twelve Months Ending 2022-09
Book Value / Share 190.86 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.30 Calculated using Price: 249.00
Dividend Yield 1.45 Period Ending 2022-03
No. of Shares Subscribed 2.14 Cr. 21,379,856 Shares
FaceValue 5
Company Profile
The company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+3.15%
1 Week
+1.28%
1 Month
+2.70%
3 Month
-1.79%
6 Month
+14.56%
1 Year
-10.62%
2 Year
5 Year
10 Year

Ratios View Details >>

5 years 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 9.07 40.92 11.74 7.70 12.87
Return on Capital Employed (%) 14.54 40.49 15.05 9.93 14.88
Return on Assets (%) 3.83 22.01 7.45 4.97 9.70

Balance Sheet View Details >>

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 125 194 210 199 395 408
Non Curr. Liab. 21 8 3 4 0 1
Curr. Liab. 143 96 125 93 94 107
Minority Int.
Equity & Liab. 289 298 338 296 489 516
Non Curr. Assets 145 177 170 102 107 112
Curr. Assets 144 120 168 194 382 404
Misc. Exp. not W/O
Total Assets 289 298 338 296 489 516

Profit Loss View Details >>

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 352 307 329 428 466 492
Other Income 4 4 2 3 7 10
Total Income 356 312 331 431 473 503
Total Expenditure -313 -269 -287 -373 -414 -436
PBIDT 44 43 44 58 59 67
Interest -6 -5 -3 -1 -1 -1
Depreciation -17 -11 -9 -13 -12 -12
Taxation -9 -12 -8 -6 -7 -9
Exceptional Items 50 -22
PAT 11 65 24 16 38 45
Minority Interest 0
Share Associate 0 -1 -7 0
Other Related Items
Consolidated Net Profit 11 64 16 16 38 45
Adjusted EPS 20 35 25 9 17 21

Cash Flow View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 35 19 25 11 9
Cash Fr. Inv. -11 -5 -14 -20 -155
Cash Fr. Finan. -26 -6 -5 1 130
Net Change -2 7 5 -8 -15
Cash & Cash Eqvt 7 13 18 16 1

Shareholding Pattern View Details >>

6 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 59.95 59.95 59.95 59.95 59.95 60.75
Public 40.05 40.05 40.05 40.05 40.05 39.25
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 07 Feb 2023
Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations 2018
Mon, 06 Feb 2023
Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations 2018
Fri, 03 Feb 2023
Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations 2018

Technical Scans View Details >>

Tue, 07 Feb 2023
High Delivery Percentage High Delivery Percentage
Closing Near 100 SMA Closing Near 100 SMA
MFI Trending Down MFI Trending Down
Mon, 06 Feb 2023
High Delivery Percentage High Delivery Percentage
CCI Bullish CCI Bullish

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,289.12 1,005.65 -1.7%
Cipla Ltd. 83,256.90 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. 73,968.14 4,441.90 +2.1%
Divi's Laboratories Ltd. 72,982.62 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. 62,135.10 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. 51,898.92 1,533.45 -0.4%
Zydus Lifesciences Ltd. 48,525.07 479.40 +2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.29 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-12 31.56 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.30 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-12 30.45 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 74.00 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.45 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.54 479.40 +2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-12 3.67 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.36 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-12 5.87 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.38 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.14 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.81 479.40 +2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 479.40 +2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.40 +2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.40 +2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 479.40 +2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 479.40 +2.0%

FAQ's On Windlas Biotech Ltd.

What is Windlas Biotech share price?
Can I buy Windlas Biotech shares now?
What is the Dividend Yield of Windlas Biotech?
What is the Market Cap of Windlas Biotech?
What are the key metrics to analyse Windlas Biotech?
What is the 52 Week High and Low of Windlas Biotech?
What is the trend of Windlas Biotech share price?